307 related articles for article (PubMed ID: 30417706)
1. Economic and epidemiological impact of dengue illness over 16 years from a public health system perspective in Brazil to inform future health policies including the adoption of a dengue vaccine.
Godói IP; Da Silva LVD; Sarker AR; Megiddo I; Morton A; Godman B; Alvarez-Madrazo S; Bennie M; Guerra-Junior AA
Expert Rev Vaccines; 2018 Dec; 17(12):1123-1133. PubMed ID: 30417706
[TBL] [Abstract][Full Text] [Related]
2. Economic impact of dengue illness and the cost-effectiveness of future vaccination programs in Singapore.
Carrasco LR; Lee LK; Lee VJ; Ooi EE; Shepard DS; Thein TL; Gan V; Cook AR; Lye D; Ng LC; Leo YS
PLoS Negl Trop Dis; 2011 Dec; 5(12):e1426. PubMed ID: 22206028
[TBL] [Abstract][Full Text] [Related]
3. Economic impact of dengue in Mexico considering reported cases for 2012 to 2016.
Zubieta-Zavala A; López-Cervantes M; Salinas-Escudero G; Ramírez-Chávez A; Castañeda JR; Hernández-Gaytán SI; López Yescas JG; Durán-Arenas L
PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006938. PubMed ID: 30550569
[TBL] [Abstract][Full Text] [Related]
4. Economic Impact of Dengue: Multicenter Study across Four Brazilian Regions.
Martelli CM; Siqueira JB; Parente MP; Zara AL; Oliveira CS; Braga C; Pimenta FG; Cortes F; Lopez JG; Bahia LR; Mendes MC; da Rosa MQ; de Siqueira Filha NT; Constenla D; de Souza WV
PLoS Negl Trop Dis; 2015; 9(9):e0004042. PubMed ID: 26402905
[TBL] [Abstract][Full Text] [Related]
5. The burden of Neglected Tropical Diseases in Brazil, 1990-2016: A subnational analysis from the Global Burden of Disease Study 2016.
Martins-Melo FR; Carneiro M; Ramos AN; Heukelbach J; Ribeiro ALP; Werneck GL
PLoS Negl Trop Dis; 2018 Jun; 12(6):e0006559. PubMed ID: 29864133
[TBL] [Abstract][Full Text] [Related]
6. The Burden of Dengue and the Financial Cost to Colombia, 2010-2012.
Castro Rodríguez R; Carrasquilla G; Porras A; Galera-Gelvez K; Lopez Yescas JG; Rueda-Gallardo JA
Am J Trop Med Hyg; 2016 May; 94(5):1065-1072. PubMed ID: 26928834
[TBL] [Abstract][Full Text] [Related]
7. Economic cost and burden of dengue during epidemics and non-epidemic years in Taiwan.
Luh DL; Liu CC; Luo YR; Chen SC
J Infect Public Health; 2018; 11(2):215-223. PubMed ID: 28757293
[TBL] [Abstract][Full Text] [Related]
8. Cost and disease burden of dengue in Cambodia.
Beauté J; Vong S
BMC Public Health; 2010 Aug; 10():521. PubMed ID: 20807395
[TBL] [Abstract][Full Text] [Related]
9. Disability adjusted life years lost to dengue in Brazil.
Luz PM; Grinsztejn B; Galvani AP
Trop Med Int Health; 2009 Feb; 14(2):237-46. PubMed ID: 19171013
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of introducing universal human papillomavirus vaccination of girls aged 11 years into the National Immunization Program in Brazil.
Novaes HM; de Soárez PC; Silva GA; Ayres A; Itria A; Rama CH; Sartori AM; Clark AD; Resch S
Vaccine; 2015 May; 33 Suppl 1():A135-42. PubMed ID: 25919154
[TBL] [Abstract][Full Text] [Related]
11. Cost-Effectiveness of Dengue Vaccination Programs in Brazil.
Shim E
Am J Trop Med Hyg; 2017 May; 96(5):1227-1234. PubMed ID: 28500811
[TBL] [Abstract][Full Text] [Related]
12. The Potential Cost Effectiveness of Different Dengue Vaccination Programmes in Malaysia: A Value-Based Pricing Assessment Using Dynamic Transmission Mathematical Modelling.
Shafie AA; Yeo HY; Coudeville L; Steinberg L; Gill BS; Jahis R; Amar-Singh Hss
Pharmacoeconomics; 2017 May; 35(5):575-589. PubMed ID: 28205150
[TBL] [Abstract][Full Text] [Related]
13. Designing a vaccination strategy against dengue.
Amaku M; Coudeville L; Massad E
Rev Inst Med Trop Sao Paulo; 2012 Oct; 54 Suppl 18():S18-21. PubMed ID: 23011455
[TBL] [Abstract][Full Text] [Related]
14. Economic cost and burden of dengue in the Philippines.
Edillo FE; Halasa YA; Largo FM; Erasmo JNV; Amoin NB; Alera MTP; Yoon IK; Alcantara AC; Shepard DS
Am J Trop Med Hyg; 2015 Feb; 92(2):360-366. PubMed ID: 25510723
[TBL] [Abstract][Full Text] [Related]
15. Economic and disease burden of dengue in Mexico.
Undurraga EA; Betancourt-Cravioto M; Ramos-Castañeda J; Martínez-Vega R; Méndez-Galván J; Gubler DJ; Guzmán MG; Halstead SB; Harris E; Kuri-Morales P; Tapia-Conyer R; Shepard DS
PLoS Negl Trop Dis; 2015 Mar; 9(3):e0003547. PubMed ID: 25786225
[TBL] [Abstract][Full Text] [Related]
16. Severity and costs associated with hospitalization for dengue in public and private hospitals of Surat city, Gujarat, India, 2017-2018.
Bajwala VR; John D; Rajasekar TD; Murhekar MV
Trans R Soc Trop Med Hyg; 2019 Nov; 113(11):661-669. PubMed ID: 31294808
[TBL] [Abstract][Full Text] [Related]
17. The global economic burden of dengue: a systematic analysis.
Shepard DS; Undurraga EA; Halasa YA; Stanaway JD
Lancet Infect Dis; 2016 Aug; 16(8):935-41. PubMed ID: 27091092
[TBL] [Abstract][Full Text] [Related]
18. Costs of dengue in three French territories of the Americas: an analysis of the hospital medical information system (PMSI) database.
Uhart M; Blein C; L'Azou M; Thomas L; Durand L
Eur J Health Econ; 2016 May; 17(4):497-503. PubMed ID: 25962729
[TBL] [Abstract][Full Text] [Related]
19. Systematic review of health economic evaluation studies of dengue vaccines.
de Soárez PC; Silva AB; Randi BA; Azevedo LM; Novaes HMD; Sartori AMC
Vaccine; 2019 Apr; 37(17):2298-2310. PubMed ID: 30910406
[TBL] [Abstract][Full Text] [Related]
20. Economic burden of dengue in Indonesia.
Nadjib M; Setiawan E; Putri S; Nealon J; Beucher S; Hadinegoro SR; Permanasari VY; Sari K; Wahyono TYM; Kristin E; Wirawan DN; Thabrany H
PLoS Negl Trop Dis; 2019 Jan; 13(1):e0007038. PubMed ID: 30629593
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
